Skip to main content

Table 1 Age standardized incidence, mortality, and 1-MIR rates per 100,000 individuals as well as LGCM results stratified by gender and super- region, 1990–2019

From: Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990–2019: a longitudinal analysis based on the global burden of disease study

Super- region

Metric

Gender

Year

     

LGCM estimates`

   

1990

1996

2002

2008

2014

2019

Intercept

Slope

 

Incidence

         
  

Female

2.03(1.95,2.11)

1.99(1.92,2.07)

1.96(1.88,2.03)

2.37(2.27,2.47)

2.43(2.33,2.53)

2.38(2.16,2.64)

3.58*

0.08**

  

Male

4.13(3.99,4.6)

4.44(4.29,4.58)

4.46(4.34,4.57)

5.31(5.15,5.45)

5.58(5.39,5.77)

5.44(4.79,6.07)

8.31*

0.11**

  

Both

2.84(2.74,2.92)

2.97(2.87,3.06)

2.96(2.88,3.04)

3.57(3.45,3.68)

3.73(3.60,3.85)

3.65(3.33,3.98)

5.62*

0.09**

CEEECA

Mortality

         
  

Female

2.15(2.06,2.24)

2.07(1.99,2.13)

2.02(1.94,2.10)

2.49(2.38,2.59)

2.51(2.38,2.60)

2.45(2.21,2.69)

3.68***

0.11*

  

Male

4.33(4.17,4.46)

4.55(4.42,4.68)

4.56(4.43,4.68)

5.53(5.33,5.71)

5.62(5.42,5.80)

5.55(4.90,6.24)

8.62*

0.15*

  

Both

2.98(2.86,3.06)

3.03(2.94,3.11)

3.02(2.93,3.10)

3.71(3.57,3.82)

3.77(3.63,3.87)

3.72(3.39,4.07)

5.76*

0.12*

 

1-MIR

         
  

Female

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

  

Male

0.00(0.00,0.00)

0.004(0,0.008)

0.002(0,0.003)

0.00(0.00,0.00)

0.006(0.005,0.007)

0.00(0.00,0.00)

0.005*

0.001**

  

Both

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

 

Incidence

         
  

Female

2.50(2.37,2.59)

3.25(3.04,3.38)

3.94(3.64,4.10)

3.99(3.62,4.18)

3.87(3.47,4.09)

3.82(3.35,4.25)

2.25***

−0.08***

  

Male

7.79(7.59,7.95)

9.96(9.67,10.20)

11.74(11.39,11.97)

11.76(11.29,12.09)

11.32(10.78,11.66)

11.20(10.05,12.50)

5.63***

−0.15***

  

Both

4.88(4.74,4.99)

6.29(6.05,6.45)

7.51(7.20,7.68)

7.58(7.17,7.81)

7.33(6.90,7.58)

7.27(6.55,8.01)

3.78***

−0.10***

HI

Mortality

         
  

Female

2.32(2.18,2.40)

2.88(2.68,2.98)

3.38(3.10,3.52)

3.30(2.96,3.48)

3.19(2.82,3.37)

3.14(2.78,3.35)

2.21***

−0.05***

  

Male

6.94(6.76,7.10)

8.60(8.33,8.78)

9.68(9.36,9.90)

9.17(8.76,9.46)

8.68(8.25,8.95)

8.55(7.94,8.97)

5.37***

−0.09***

  

Both

4.38(4.23,4.48)

5.44(5.20,5.56)

6.24(5.94,6.40)

5.98(5.61,6.18)

5.71(5.31,5.91)

5.65(5.23,5.95)

3.63***

−0.08***

 

1-MIR

         
  

Female

0.04(0.03,0.06)

0.09(0.08,0.10)

0.10(0.12,0.11)

0.13(0.11,0.14)

0.13(0.14,0.15)

0.12(0.11,0.16)

0.12***

0.002***

  

Male

0.11(0.10,0.12)

0.13(0.11,0.14)

0.17(0.16,0.18)

0.22(0.21,0.23)

0.22(0.20,0.23)

0.22(0.19,0.26)

0.16***

0.003***

  

Both

0.09(0.08,0.10)

0.12(0.11,0.13)

0.15(0.15,0.17)

0.19(0.18,0.20)

0.19(0.17,0.20)

0.19(0.18,0.22)

0.15***

0.002***

 

Incidence

         
  

Female

3.00(2.84,3.17)

2.65(2.51,2.76)

2.13(2.02,2.22)

2.18(2.06,2.27)

2.27(2.12,2.38)

2.26(2.03,2.51)

2.11***

0.01*

  

Male

3.61(3.41,3.81)

3.32(3.14,3.49)

2.95(2.76,3.11)

3.28(3.09,3.45)

3.66(3.47,3.82)

3.72(3.37,4.14)

3.40***

0.03*

  

Both

3.30(3.14,3.43)

2.97(2.83,3.07)

2.52(2.38,2.63)

2.69(2.54,2.82)

2.91(2.75,3.03)

2.93(2.66,3.27)

2.46***

0.02*

LAC

Mortality

         
  

Female

3.23(3.03,3.40)

2.81(2.65,2.94)

2.29(2.14,2.39)

2.30(2.15,2.42)

2.43(2.27,2.54)

2.40(2.16,2.67)

2.41***

0.07**

  

Male

3.84(3.61,4.05)

3.50(3.30,3.69)

3.16(2.96,3.35)

3.45(3.22,3.64)

3.88(3.66,4.06)

3.95(3.57,4.38)

3.28***

0.11*

  

Both

3.52(3.33,3.67)

3.14(2.97,3.27)

2.70(2.53,2.82)

2.83(2.65,2.97)

3.09(2.92,3.22)

3.11(2.82,3.44)

2.86***

0.09*

 

1-MIR

         
  

Female

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

  

Male

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

  

Both

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

 

Incidence

         
  

Female

3.92(3.12,4.81)

3.68(3.19,4.20)

3.42(3.13,3.73)

3.87(3.55,4.23)

4.17(3.76,4.75)

4.10(3.44,4.97)

3.93***

0.01**

  

Male

8.18(7.08,9.30)

7.78(7.05,8.58)

7.79(7.27,8.33)

8.68(8.03,9.42)

8.93(7.84,10.22)

8.40(6.60,10.63)

6.46***

0.03**

  

Both

6.08(5.28,6.81)

5.76(5.24,6.25)

5.64(5.29,5.99)

6.31(5.91,6.81)

6.59(5.93,7.42)

6.29(5.13,7.71)

5.30***

0.02**

NAME

Mortality

         
  

Female

4.13(3.28,5.12)

3.83(3.27,4.43)

3.61(3.28,3.93)

3.87(3.51,4.24)

3.95(3.55,4.45)

3.69(3.10,4.51)

4.30***

−0.001**

  

Male

8.62(7.48,9.79)

8.18(7.39,9.08)

8.41(7.76,9.07)

8.67(8.00,9.38)

9.16(8.12,10.28)

8.63(6.81,10.83)

7.06***

−0.003**

  

Both

6.39(5.55,7.19)

6.03(5.47,6.55)

6.04(5.62,6.42)

6.31(5.90,6.74)

6.59(5.99,7.31)

6.20(5.06,7.62)

5.79***

−0.003**

 

1-MIR

         
  

Female

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.04(0.05,0.04)

0.09(0.09,0.10)

0.13(0.13,0.12)

−0.007***

0.001**

  

Male

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.02(0.02,0.03)

0.00(0.00,0.02)

0.00(0.00,0.00)

0.004***

0.007**

  

Both

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.03(0.03,0.04)

0.03(0.02,0.04)

0.04(0.04,0.04)

−0.005*

0.003*

 

Incidence

         
  

Female

1.96(1.54,2.45)

2.01(1.58,2.44)

2.05(1.65,2.43)

2.00(1.63,2.34)

1.98(1.67,2.29)

1.95(1.54,2.47)

  

Male

3.29(2.64,3.91)

3.38(2.75,3.88)

3.52(2.96,3.91)

3.53(3.04,3.87)

3.45(3.13,3.76)

3.38(2.86,3.99)

  

Both

2.66(2.20,3.08)

2.72(2.25,3.09)

2.79(2.37,3.11)

2.77(2.37,3.04)

2.70(2.42,2.94)

2.66(2.30,3.05)

SAa

Mortality

         
  

Female

2.13(1.66,2.70)

2.18(1.74,2.67)

2.25(1.80,2.66)

2.22(1.82,2.59)

2.08(1.74,2.44)

2.09(1.61,2.67)

  

Male

3.46(2.78,4.07)

3.61(2.93,4.13)

3.74(3.13,4.19)

3.78(3.27,4.18)

3.59(3.28,3.92)

3.56(2.98,4.18)

  

Both

2.82(2.33,3.27)

2.92(2.44,3.32)

3.01(2.54,3.35)

3.00(2.59,3.30)

2.82(2.56,3.09)

2.81(2.43,3.24)

 

1-MIR

         
  

Female

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

  

Male

0.00(0.00,0.01)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

  

Both

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

 

Incidence

         
  

Female

12.17(10.133,14.70)

12.18(10.91,13.77)

8.39(7.78,9.18)

5.17(4.79,5.58)

4.75(4.30,5.20)

4.75(3.97,5.61)

6.11***

−0.05***

  

Male

29.69(24.58,35.49)

33.06(30.15,36.51)

23.46(21.73,25.32)

13.61(12.66,14.74)

13.85(12.57,15.34)

14.66(12.12,17.59)

12.63***

−0.10*

  

Both

20.85(17.91,24.30)

22.50(20.94,24.41)

15.77(14.85,16.83)

9.27(8.71,9.98)

9.14(8.44,9.89)

9.52(8.19,11.01)

9.35***

−0.09*

SAEAO

Mortality

         
  

Female

12.70(10.53,15.36)

12.69(11.24,14.47)

8.10(7.25,9.15)

5.36(4.92,5.82)

4.73(4.27,5.22)

4.67(3.93,5.52)

6.38***

−0.07***

  

Male

29.87(24.72,35.64)

33.42(30.05,37.20)

21.42(19.21,23.77)

13.61(12.49,14.79)

12.89(11.35,14.40)

13.40(11.17,15.84)

13.05***

−0.05***

  

Both

21.13(18.37,24.44)

22.84(20.90,24.88)

14.56(13.37,15.89)

9.31(8.67,9.97)

8.61(7.84,9.43)

8.82(7.65,10.09)

9.60***

−0.05*

 

1-MIR

         
  

Female

0.00(0.00,0.00)

0.00(0.00,0.00)

0.06(0.04,0.08)

0.00(0.00,0.00)

0.02(0.01,0.03)

0.03(0.02,0.04)

0.006

  

Male

0.03(0.01,0.05)

0.02(0.01,0.04)

0.15(0.12,0.18)

0.04(0.03,0.06)

0.13(0.10,0.15)

0.11(0.09,0.12)

0.01

  

Both

0.02(0.01,0.04)

0.03(0.01,0.05)

0.11(0.08,0.13)

0.03(0.02,0.05)

0.10(0.08,0.12)

0.09(0.08,0.10)

0.01

 

Incidence

         
  

Female

3.31(2.83,3.95)

3.40(2.94,3.93)

3.37(2.94,3.84)

3.17(2.78,3.54)

3.06(2.69,3.43)

2.90(2.52,3.31)

3.73*

−0.002*

  

Male

5.61(4.57,7.59)

6.68(5.99,7.60)

6.88(6.19,7.66)

6.34(5.73,7.00)

6.05(5.47,6.67)

5.75(5.09,6.46)

8.14***

−0.03*

  

Both

4.43(3.77,5.54)

4.99(4.49,5.52)

5.05(4.57,5.59)

4.67(4.24,5.11)

4.45(4.05,4.89)

4.22(3.77,4.71)

5.90***

−0.01*

SSA

Mortality

         
  

Female

3.54(3.05,4.22)

3.63(3.16,4.17)

3.55(3.07,4.05)

3.37(2.95,3.76)

3.30(2.89,3.70)

3.13(2.72,3.59)

3.85***

−0.02***

  

Male

6.01(4.91,8.14)

7.29(6.55,8.28)

7.41(6.58,8.32)

6.80(6.08,7.54)

6.54(5.88,7.20)

6.19(5.46,6.91)

10.56***

−0.05*

  

Both

4.73(4.01,5.93)

5.38(4.83,5.96)

5.38(4.83,5.99)

4.98(4.49,5.48)

4.80(4.35,5.26)

4.53(4.03,5.04)

5.95***

−0.03*

 

1-MIR

         
  

Female

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

  

Male

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

  

Both

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

0.00(0.00,0.00)

 

Incidence

         
  

Female

5.22(4.62,5.96)

5.55(5.14,6.04)

4.69(4.40,4.95)

3.80(3.56,3.98)

3.66(3.40,3.87)

3.63(3.23,4.05)

3.99***

−0. 03***

  

Male

13.07(11.42,14.87)

15.02(14.06,16.16)

12.63(12.02,13.26)

9.60(9.18,10.06)

9.59(9.07,10.11)

9.71(8.69,10.84)

7.91***

−0. 08*

  

Both

8.98(8.10,9.97)

10.09(9.56,10.70)

8.47(8.10,8.84)

6.55(6.25,6.82)

6.47(6.11,6.77)

6.51(5.95,7.16)

5.83***

−0. 07*

Global

Mortality

         
  

Female

5.33(4.67,6.09)

5.59(5.15,6.11)

4.47(4.15,4.80)

3.72(3.44,3.91)

3.51(3.22,3.74)

3.46(3.08,3.83)

4.17***

−0. 02***

  

Male

12.90(11.30,14.67)

14.76(13.65,15.99)

11.48(10.70,12.29)

9.00(8.55,9.45)

8.66(8.10,9.22)

8.73(7.88,9.60)

8.14***

−0. 07*

  

Both

8.93(8.09,9.90)

9.95(9.32,10.60)

7.78(7.35,8.20)

6.20(5.87,6.46)

5.93(5.59,6.24)

5.95(5.44,6.44)

6.03***

−0. 06*

 

1-MIR

         
  

Female

0.00(0.00,0.00)

0.01(0.00,0.03)

0.07(0.05,0.09)

0.04(0.03,0.06)

0.05(0.05,0.03)

0.04(0.02,0.05)

0.006

0.01*

  

Male

0.04(0.02,0.05)

0.05(0.04,0.07)

0.11(0.09,0.13)

0.09(0.08,0.11)

0.11(0.10,0.13)

0.11(0.10,0.13)

0.01

0.01*

  

Both

0.02(0.01,0.03)

0.04(0.03,0.07)

0.09(0.08,0.11)

0.07(0.06,0.09)

0.09(0.06,0.10)

0.09(0.07,0.11)

0.01

0.01*

  1. Data in parentheses are 95% uncertainty intervals
  2. CEEECA Central Europe, Eastern Europe, and Central Asia, HI High Income, LAC Latin America and Caribbean, NAME North Africa and Middle East, SA South Asia, SAEAO Southeast Asia, East Asia, and Oceania, SSA Sub-Saharan Africa, MIR Mortality-to-incidence ratio, LGCM Latent growth curve model
  3. * p<0.05, ** p>0.05, *** p<0.001
  4. aNot fitted LGCM, due to inadequate number of countries